KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments: 2009-2025

Historic Change in Acquisitions & Divestments for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Sep 2025 value amounting to $20.7 million.

  • Rigel Pharmaceuticals' Change in Acquisitions & Divestments rose 245.50% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 million, marking a year-over-year increase of 39.49%. This contributed to the annual value of $39.7 million for FY2024, which is 4.68% down from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Change in Acquisitions & Divestments stood at $20.7 million, which was up 31.62% from $15.8 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $30.9 million during Q4 2021, with a 5-year trough of $1.4 million in Q3 2021.
  • For the 3-year period, Rigel Pharmaceuticals' Change in Acquisitions & Divestments averaged around $11.7 million, with its median value being $11.1 million (2025).
  • In the last 5 years, Rigel Pharmaceuticals' Change in Acquisitions & Divestments crashed by 96.54% in 2021 and then soared by 2,002.72% in 2022.
  • Rigel Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $30.9 million in 2021, then plummeted by 31.39% to $21.2 million in 2022, then plummeted by 71.65% to $6.0 million in 2023, then rose by 12.50% to $6.8 million in 2024, then soared by 245.50% to $20.7 million in 2025.
  • Its Change in Acquisitions & Divestments was $20.7 million in Q3 2025, compared to $15.8 million in Q2 2025 and $11.1 million in Q1 2025.